PET Imaging of [18F]Dabrafenib Distribution and Kinetics in Brain Metastasis in Patients With BRAF Positive Metastastic Melanoma. A Feasibility Study.
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Dabrafenib (Primary)
- Indications Malignant melanoma
- Focus Pharmacokinetics
- 26 Sep 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2018.
- 26 Sep 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2018.
- 26 Sep 2017 Status changed from not yet recruiting to recruiting.